National Heart, Lung, and Blood Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2020-11125"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2020-11125"
section_name: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
positive_law: false
currency: "2020-05-22"
last_updated: "2020-05-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
document_number: "2020-11125"
document_type: "notice"
publication_date: "2020-05-22"
agencies:
  - "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
  - "National Institutes of Health"
---


#  National Heart, Lung, and Blood Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the SINGLE-SITE AND PILOT CLINICAL TRIALS REVIEW COMMITTEE, June 24, 2020, 08:00 a.m. to June 25, 2020, 05:00 p.m., National Institute of Health (NIH), Rockledge 1, 6705 Rockledge Drive, Bethesda, MD 20892 which was published in the *Federal Register* on May 18, 2020, 85 FR 29732. The NHLBI Initial/Integrated Review Group meeting is being amended to change the meeting start time to 9:00 a.m. and end time to 3:00 p.m. This two-day meeting to be held on June 24-25, 2020 will be a teleconference meeting. The meeting is closed to the public.

Dated: May 19, 2020.

Ronald J. Livingston, Jr.,

Program Analyst, Office of Federal Advisory Committee Policy.